REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medifron DBT Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Data Processing, Hosting, and Related Services | All Other Business Support Services
Full name: Medifron DBT Co.,Ltd. Profile Updated: June 29, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Medifron DBT Co.,Ltd. is a company based in South Korea, with its head office in Seoul. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was established on March 18, 1997. The total number of employees is currently 94 (2024). In Q3C2025, the company reported a net sales revenue increase of 24.69%. Its’ total assets recorded a growth of 1.41%.

Headquarters
1401 A-Dong Woolim Blue9 Business Center, 240-21 Yeomchang-Dong, Gangseo-Gu
Seoul; Seoul;

Contact Details: Purchase the Medifron DBT Co.,Ltd. report to view the information.

Website: http://medifon.com

Basic Information
Total Employees:
Purchase the Medifron DBT Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Medifron DBT Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Medifron DBT Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Medifron DBT Co.,Ltd. report to view the information.
Incorporation Date:
March 18, 1997
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Technology Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
3.05%
Purchase this report to view the information.
2.96%
Purchase this report to view the information.
2.51%
Purchase this report to view the information.
2.45%
Purchase this report to view the information.
0.09%
Company Performance
Financial values in the chart are available after Medifron DBT Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
24.69%▲
Total Operating Revenue
87.41%▲
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
1.41%▲
Total Equity
-63.05%▼
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
234273%▲
Quick Ratio
-453.92%▼
Cash Ratio
0.11%▲

Similar companies

Cj Cheiljedang Corporation
 
Kt&G Corporation
Amore Pacific Group
 
Samsung Biologics Co., Ltd.
Green Cross Holdings Corporation
 
Yuhan Corporation
KPX Life Science Co.,Ltd.
 
Naturalendo Tech Co.,Ltd.
HUMASIS CO., LTD.
 
Tium Bio Co.,Ltd.
Optipharm Co.,Ltd
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo